Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus

Magnus Halland, David Katzka, Prasad GIyer

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


The burden of illness from esophageal adenocarcinoma continues to rise in the Western world, and overall prognosis is poor. Given that Barrett's esophagus (BE), a metaplastic change in the esophageal lining is a known cancer precursor, an opportunity to decrease disease development by screening and surveillance might exist. This review examines recent updates in the pathogenesis of BE and comprehensively discusses known risk factors. Diagnostic definitions and challenges are outlined, coupled with an in-depth review of management. Current challenges and potential solutions related to screening and surveillance are discussed. The effectiveness of currently available endoscopic treatment techniques, particularly with regards to recurrence following successful endotherapy and potential chemopreventative agents are also highlighted. The field of BE is rapidly evolving and improved understanding of pathophysiology, combined with emerging methods for screening and surveillance offer hope for future disease burden reduction.

Original languageEnglish (US)
Pages (from-to)6479-6490
Number of pages12
JournalWorld journal of gastroenterology
Issue number21
StatePublished - Jun 7 2015


  • Barrett's esophagus
  • Esophageal cancer
  • Esophagus
  • Gastroesophageal reflux disease

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus'. Together they form a unique fingerprint.

Cite this